Nervgen Pharma NGEN
NASDAQ NGEN
$1.50 -0.04 (-2.60%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Liabilities and Shareholders Equity (2024 - 2026)

Updated

Nervgen Pharma (NGEN) recorded Liabilities and Shareholders Equity of $65.2 million in the quarter ended Jun 30, 2026, up 330.6% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma reported Liabilities and Shareholders Equity of $16.61 million, up 16.7% from the prior year.

  • Across earlier years, Liabilities and Shareholders Equity came in at $14.23 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Nervgen Pharma 108.50 Mn 7.38 Mn - 63.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.47 Mn
Mar 31, 2026 14.91 Mn
Dec 31, 2025 16.95 Mn
Dec 31, 2024 13.58 Mn
API Access

Nervgen Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NGEN&period=max&api_key=YOUR_API_KEY